Regadenoson is Used for cardiac imaging and increasing coronary blood flow. It was first introduced by Astellas Pharma Us Inc in its drug Lexiscan on Apr 10, 2008. 14 different companies have introduced drugs containing Regadenoson.

Regadenoson Patents

Given below is the list of patents protecting Regadenoson, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Lexiscan	US8106183	Process for preparing an A2A-adenosine receptor agonist and its polymorphs	Feb 02, 2027	Astellas
Lexiscan	US9085601	Process for preparing an A2A-adenosine receptor agonist and its polymorphs	Feb 02, 2027	Astellas
Lexiscan	USRE47301	Process for preparing an A2A-adenosine receptor agonist and its polymorphs	Feb 02, 2027	Astellas
Lexiscan	US6403567	N-pyrazole A2A adenosine receptor agonists	Apr 10, 2022 (Expired)	Astellas
Lexiscan	US6642210	2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US7144872	N-pyrazole A2A receptor agonists	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US7183264	N-pyrazole A2A receptor agonists	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US7582617	Myocardial perfusion imaging method	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US7655636	Use of A2A adenosine receptor agonists	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US7655637	N-pyrazole A2A receptor agonists	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US7683037	Myocardial perfusion imaging method	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US8106029	Use of A2A adenosine receptor agonists	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US8133879	Myocardial perfusion imaging methods and compositions	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US8183226	Myocardial perfusion imaging method	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US8470801	Myocardial perfusion imaging methods and compositions	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US8536150	Methods of myocardial perfusion imaging	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US9045519	N-pyrazole A2A receptor agonists	Jun 22, 2019 (Expired)	Astellas
Lexiscan	US9289446	Myocardial perfusion imaging methods and compositions	Jun 22, 2019 (Expired)	Astellas
Lexiscan	USRE47351	2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists	Jun 22, 2019 (Expired)	Astellas

Add above patents to watchlist

Regadenoson's Family Patents

Full family tree

Regadenoson Generic API Manufacturers

Several generic applications have been filed for Regadenoson. The first generic version for Regadenoson was by Accord Healthcare Inc and was approved on Apr 11, 2022. And the latest generic version is by Indies Pharma Jamaica Ltd and was approved on Aug 22, 2024.

Given below is the list of companies who have filed for Regadenoson generic, along with the locations of their manufacturing plants worldwide.